3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
2
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Lung Neoplasms
4
Multiple Pulmonary Nodules
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Solitary Pulmonary Nodule
1
Smoking Cessation
1
Small Cell Lung Carcinoma
1
Recurrence
1
Melanoma
1
Lymphoma, Follicular
1
Lung Diseases
1
Inflammatory Bowel Diseases
1
Head and Neck Neoplasms
1
Glioma
1
Depressive Disorder, Major
1
Breast Neoplasms
1
Breast Neoplasm Female
1
Bone Neoplasms
1
Barrett Esophagus
1
Adenocarcinoma of Lung
1
Adenocarcinoma
1
Interventions
Endoscopy, Digestive System
7
Endoscopy
7
Esomeprazole
6
Biopsy
5
Radiofrequency Ablation
4
Omeprazole
4
Specimen Handling
3
Gastroscopy
3
Aspirin
3
YF 476
2
Proflavine
2
Photochemotherapy
2
Microscopy, Confocal
2
Metformin
2
Endoscopic Mucosal Resection
2
Endoscopes
2
Cryosurgery
2
2-(1-hexyloxyethyl)-2-devinyl pyropheophorbide-a
2
rofecoxib
1
polyphenon E
1
plecanatide
1
linaclotide
1
chlorhexidine gluconate
1
candesartan cilexetil
1
candesartan
1
Ursodeoxycholic Acid
1
Tomography, Optical Coherence
1
Sunitinib
1
Standard of Care
1
Narrow Band Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Barrett Esophagus
×
Diagnostic Imaging
×
Clear all
NCT00795184
2016-05-03
DONTBIOPCE
Mauna Kea Technologies
Phase NA
Completed
122 enrolled
5 charts